Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biochem Pharma (BCHE) -- Ignore unavailable to you. Want to Upgrade?

To: Del Holmes who wrote (280)	4/14/1998 9:56:00 AM
From: Ludo	Read Replies (1) \| Respond to of 783

>I think the drop yesterday was probably more related to the fact >that the Canadian Dollar dropped below .70 yesterday which is not >good new if BCHE reports earnings this week Del, can you give more details on the impact of the Can/US rates on BCHE? I hold some BCHE both in my canadian brokerage account and in a US$ account, so I'm interested in understanding the fine impact. For the company that is, not on a short term speculation movement like yesterday. Since they receive worldwide rights and revenues for their drugs and vaccines (and whatever else), the currency impact is not couterbalanced on the revenue column too? Are you only talking about the revenues done previously in the current quarter that will fade a bit on the balance sheet? Please give me more details since understanding the business of a company in every aspects is something I really care about. Thank you. Ludo